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T.V. Schroeder*
Vascular Surgery, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, DenmarkI ﬁnd the conclusion of this report quite attractive and in line
with recent research: invasive treatment of carotid stenosis may
not be warranted in most patients >80 years of age with carotid
stenosis, especially when female and asymptomatic. However, I am
not sure that the data set actually allows this conclusion. We are
presented with a 9-year case material of all 80e91-year-old
patients analysed retrospectively including two different proce-
dures of which angioplasty was used minimally during the last
years. The data set was stratiﬁed according to gender and preop-
erative symptoms.
Primary end point was perioperative stroke/death, which
occurred in 19 cases. A total of 323 patients (270 (84%) men and
53 (16%) women) had 348 procedures (272 in men and 76 in
women). This discloses a surprising skewness in the data set:
bilateral procedures were performed in 23 women but in only
two men. Is this a reﬂection of female patients being more
diseased? The reported higher rate of peripheral vascular disease
among female patients supports this impression. Add to this, that
the high risk among women in the data set was based on only ﬁve
incidents. Outcome in several subgroups was compared. Even
though outcome was two to three times worse in one group as
compared to another, none reached the level of signiﬁcance.DOI of original article: 10.1016/j.ejvs.2012.06.006.
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http://dx.doi.org/10.1016/j.ejvs.2012.07.004A rough power calculation could have guided the authors: the
case material had to be 3e4 times larger to reach statistical
signiﬁcance.
Secondary end point was 5-year ischaemic stroke/death. Here
we are faced with new challenges: median follow-up was only 3
years, and 5-year mortality was calculated alternatively, as only the
dead and those observed for at least 5 years were analysed. Out of
the total 323 patients, only 160 were included into the long-term
outcome calculations: 79 who died within 5 years and 81 alive
and observed for 5 years. Thus survival information in 163 patients
was disregarded. Consequently, the 5-year all-cause mortality was
49% (79/160), corresponding to a survival rate of 51% e which was
substantially lower than the KM calculated 5 years survival of 65%.
We are not surprised then, those outcomes based on the limited
data set are less favourable than those of the local 80e85-year-old
population.
With these examples, I would like to emphasise the importance
of being cautious when subgroup analysis is performed on a limited
case material collected over a number of years and analysed
retrospectively. Bias is often unavoidable and neither easy to detect
nor easy to correct. In addition, bias may be the cause for observed
differences credited to clinical parameters.ed by Elsevier Ltd. All rights reserved.
